A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD



Status:Active, not recruiting
Conditions:Neurology, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:6 - 17
Updated:1/11/2017
Start Date:February 2016
End Date:January 2017

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

This noninterventional study will assess genomic changes in the metabotropic glutamate
receptor (mGluR) network in children and adolescents with ADHD.

Male and female subjects 6 to 17 years of age with a primary psychiatric diagnosis of ADHD
will be enrolled in this study. The subject and his or her parent/guardian must agree to
genotyping to determine whether the subject has disruptive mutations within any of the
approximately 274 mGluR-network genes, and complete an interview that will include
information about the subject's ADHD history, treatment, and co-morbidities.

Inclusion Criteria:

- The subject is male or female ≥6 and ≤17 years of age.

- The subject has ADHD as defined by the Diagnostic and Statistical Manual of Mental
Disorders, 5th edition.

- The subject, his or her legally responsible representative, and investigator agree to
complete ADHD history, treatment, and comorbidity electronic case report form (eCRF).

Exclusion Criteria:

- The subject or parent/legal guardian is in the opinion of the investigator mentally
or legally incapacitated and unable to provide informed consent/assent for
participation in the study.
We found this trial at
1
site
A.I. Dupont Hospital for Children
Wilmington, Delaware 19803
Phone: 302-651-4000
?
mi
from
Wilmington, DE
Click here to add this to my saved trials